Sanofi's Strategic Share Repurchase

In a significant move to bolster its financial strategy, Sanofi S.A. revealed plans on Monday to repurchase 2.3% of its shares from L'Oreal S.A. This transaction, part of a broader share buyback initiative announced on January 30, involves acquiring 29,556,650 shares at €101.50 each, marking a 2.8% discount from the closing price on January 31, 2025.

Strengthening Ties with L'Oreal

Following this €3 billion deal, L'Oreal's stake in Sanofi will adjust to 7.2%, with 13.1% of voting rights retained. Sanofi's Chief Financial Officer, Francois Roger, emphasized the enduring partnership with L'Oreal, stating, "L'Oreal has been a trusted shareholder and partner for decades, playing a key role in supporting Sanofi’s growth and transformation. We are pleased to retain L'Oreal as one of our largest shareholders." This transaction underscores Sanofi's commitment to sustainable value creation while maintaining strategic priorities and strengthening key partnerships.